{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=placebo&page=38", "query": { "intervention": "placebo", "page": 38 }, "page_size": 10 }, "pagination": { "page": 38, "page_size": 10, "total_count": 4149, "total_pages": 415, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=placebo&page=39&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=placebo&page=37&page_size=10" }, "source": "local", "last_synced_at": "2026-10-21T05:53:27.310Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07502443", "title": "A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Narcolepsy Type 2" ], "interventions": [ { "name": "ALKS 2680 Dose 1", "type": "DRUG" }, { "name": "ALKS 2680 Dose 2", "type": "DRUG" }, { "name": "ALKS 2680 Dose 3", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alkermes, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 176, "start_date": "2026-04-22", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2026-10-07", "last_synced_at": "2026-10-14T13:11:42.290Z", "location_count": 23, "location_summary": "Cullman, Alabama • Phoenix, Arizona • Los Angeles, California + 20 more", "locations": [ { "city": "Cullman", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Brandon", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07502443" }, { "nct_id": "NCT07455383", "title": "A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Narcolepsy Type 1" ], "interventions": [ { "name": "ALKS 2680 Dose 1", "type": "DRUG" }, { "name": "ALKS 2680 Dose 2", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alkermes, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 150, "start_date": "2026-04-06", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2026-10-07", "last_synced_at": "2026-10-13T18:46:10.778Z", "location_count": 22, "location_summary": "Cullman, Alabama • Phoenix, Arizona • Los Angeles, California + 19 more", "locations": [ { "city": "Cullman", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Brandon", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07455383" }, { "nct_id": "NCT07420283", "title": "A Study of Brenipatide in Participants With Opioid Use Disorder", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Opioid Use Disorder" ], "interventions": [ { "name": "Brenipatide", "type": "DRUG" }, { "name": "Buprenorphine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 465, "start_date": "2026-02-13", "completion_date": "2028-03", "has_results": false, "last_update_posted_date": "2026-10-07", "last_synced_at": "2026-10-13T22:43:45.993Z", "location_count": 40, "location_summary": "Phoenix, Arizona • Little Rock, Arkansas • Fountain Valley, California + 30 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07420283" }, { "nct_id": "NCT07410507", "title": "A Study of Brenipatide in Adult Participants With Schizophrenia", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Brenipatide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 450, "start_date": "2026-02-10", "completion_date": "2027-11", "has_results": false, "last_update_posted_date": "2026-10-07", "last_synced_at": "2026-10-21T05:53:27.310Z", "location_count": 32, "location_summary": "Little Rock, Arkansas • Bellflower, California • Garden Grove, California + 28 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Bellflower", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Montclair", "state": "California" }, { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07410507" }, { "nct_id": "NCT07359846", "title": "A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Severe Asthma" ], "interventions": [ { "name": "GB-0895", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Generate Biomedicines", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "12 Years to 80 Years" }, "enrollment_count": 786, "start_date": "2026-01-20", "completion_date": "2029-01", "has_results": false, "last_update_posted_date": "2026-10-07", "last_synced_at": "2026-10-16T07:43:48.565Z", "location_count": 20, "location_summary": "Bakersfield, California • Inglewood, California • Lancaster, California + 15 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "Inglewood", "state": "California" }, { "city": "Lancaster", "state": "California" }, { "city": "West Covina", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07359846" }, { "nct_id": "NCT07299019", "title": "A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Secondary Progressive Multiple Sclerosis" ], "interventions": [ { "name": "Orelabrutinib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Zenas BioPharma (USA), LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 990, "start_date": "2026-03-23", "completion_date": "2030-07", "has_results": false, "last_update_posted_date": "2026-10-07", "last_synced_at": "2026-10-14T13:11:27.368Z", "location_count": 26, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Fullerton, California + 22 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Fullerton", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "West Hollywood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07299019" }, { "nct_id": "NCT07286175", "title": "A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bipolar Disorder" ], "interventions": [ { "name": "Brenipatide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 400, "start_date": "2025-11-24", "completion_date": "2027-11", "has_results": false, "last_update_posted_date": "2026-10-07", "last_synced_at": "2026-10-14T01:17:32.314Z", "location_count": 20, "location_summary": "Orange, California • New Haven, Connecticut • Hialeah, Florida + 16 more", "locations": [ { "city": "Orange", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Maitland", "state": "Florida" }, { "city": "Maitland", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07286175" }, { "nct_id": "NCT07285213", "title": "Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Clostridioides Difficile Infection" ], "interventions": [ { "name": "AZD5148", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 230, "start_date": "2025-12-10", "completion_date": "2028-01-18", "has_results": false, "last_update_posted_date": "2026-10-07", "last_synced_at": "2026-10-16T16:48:05.538Z", "location_count": 43, "location_summary": "Phoenix, Arizona • Chula Vista, California • Sacramento, California + 39 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Chula Vista", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Hamden", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT07285213" }, { "nct_id": "NCT07282340", "title": "Phentermine's Impact on Treatment in Teens", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Childhood Obesity" ], "interventions": [ { "name": "Phentermine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Russell McCulloh, MD", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 240, "start_date": "2026-06-03", "completion_date": "2028-01", "has_results": false, "last_update_posted_date": "2026-10-07", "last_synced_at": "2026-10-13T18:44:37.873Z", "location_count": 8, "location_summary": "Wilmington, Delaware • Louisville, Kentucky • Baton Rouge, Louisiana + 5 more", "locations": [ { "city": "Wilmington", "state": "Delaware" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Baton Rouge", "state": "Louisiana" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "Lebanon", "state": "New Hampshire" } ], "official_url": "https://clinicaltrials.gov/study/NCT07282340" }, { "nct_id": "NCT07276724", "title": "A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Severe Asthma" ], "interventions": [ { "name": "GB-0895", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Generate Biomedicines", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "12 Years to 80 Years" }, "enrollment_count": 786, "start_date": "2025-12-03", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2026-10-07", "last_synced_at": "2026-10-14T12:11:49.350Z", "location_count": 36, "location_summary": "Northridge, California • Pasadena, California • Rancho Cucamonga, California + 31 more", "locations": [ { "city": "Northridge", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "Rancho Cucamonga", "state": "California" }, { "city": "Valencia", "state": "California" }, { "city": "West Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07276724" } ] }